Ligand Pharmaceuticals Inc
NASDAQ:LGND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
US |
|
H
|
HSBC Holdings PLC
XBER:HBC1
|
UK |
|
K
|
Kalbe Farma Tbk PT
F:LCLA
|
ID |
|
Telecom Italia SpA
MIL:TIT
|
IT |
|
Franklin Resources Inc
NYSE:BEN
|
US |
|
S
|
Shaw Communications Inc
F:SWC
|
CA |
|
E
|
Eastern Polymer Group PCL
SET:EPG
|
TH |
|
Avalonbay Communities Inc
NYSE:AVB
|
US |
|
F
|
Fortress Transportation and Infrastructure Investors LLC
NASDAQ:FTAI
|
US |
|
Escorts Kubota Ltd
NSE:ESCORTS
|
IN |
|
Renalytix PLC
LSE:RENX
|
UK |
|
C
|
Carlsberg A/S
F:CBGA
|
DK |
Wall St Price Targets
LGND Price Targets Summary
Ligand Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for LGND is 333.95 USD with a low forecast of 249.47 USD and a high forecast of 407.4 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LGND's stock price target?
Price Target
333.95
USD
According to Wall Street analysts, the average 1-year price target for LGND is 333.95 USD with a low forecast of 249.47 USD and a high forecast of 407.4 USD.
What is the Revenue forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 8 years is 19%.
What is the Gross Profit forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 7 years is 21%.
What is the Pre-Tax Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
25%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 25%.
What is the Net Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
26%
The compound annual growth rate for Net Income over the next 7 years is 26%.
